HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K L Black Selected Research

K L Black Research Topics

Disease

8Neoplasms (Cancer)
02/2013 - 12/2000
6Glioma (Gliomas)
09/2001 - 01/2000
3Brain Neoplasms (Brain Tumor)
03/2006 - 12/2000
2Astrocytoma (Pilocytic Astrocytoma)
07/2001 - 02/2001
2Glioblastoma (Glioblastoma Multiforme)
02/2001 - 12/2000
1Meningioma (Meningiomas)
02/2013
1Cross Infection (Nosocomial Infection)
02/2013
1Urinary Tract Infections (Urinary Tract Infection)
02/2013
1Pituitary Neoplasms (Pituitary Adenoma)
07/2009
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2006
1Brain Ischemia (Cerebral Ischemia)
09/2001
1Ischemia
09/2001
1Virus Diseases (Viral Diseases)
04/2001
1Alphavirus Infections
01/2001
1Infratentorial Neoplasms (Posterior Fossa Tumors)
12/2000

Drug/Important Bio-Agent (IBA)

4AntigensIBA
06/2001 - 01/2000
2Proteins (Proteins, Gene)FDA Link
07/2009 - 03/2006
2AcidsIBA
09/2001 - 12/2000
2BradykininIBA
09/2001 - 06/2001
2CytokinesIBA
06/2001 - 01/2000
2Peptides (Polypeptides)IBA
02/2001 - 12/2000
2VaccinesIBA
02/2001 - 12/2000
1Cell Cycle ProteinsIBA
02/2013
1Hormones (Hormone)IBA
07/2009
1Antipyrine (Phenazone)FDA Link
09/2001
1Phosphates (Orthophosphate)IBA
09/2001
1salicylhydroxamic acid (SHAM)IBA
09/2001
1Nitric Oxide Synthase (NO Synthase)IBA
09/2001
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2001
1Dextrans (Dextran)FDA Link
09/2001
1Laminin (Merosin)IBA
07/2001
1laminin AIBA
07/2001
1laminin 9IBA
07/2001
1ErbB Receptors (EGF Receptor)IBA
07/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2001
1laminin 8IBA
07/2001
1Protein Isoforms (Isoforms)IBA
07/2001
1Interferon-gamma (Interferon, gamma)IBA
06/2001
1Green Fluorescent ProteinsIBA
04/2001
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
01/2001
1Antiviral Agents (Antivirals)IBA
01/2001
1Nucleic Acid-Based VaccinesIBA
01/2001

Therapy/Procedure

2Immunotherapy
01/2001 - 12/2000
1Craniotomy
02/2013
1Urinary Catheters
02/2013
1Therapeutics
04/2001